{"schema_version":"1","generated_at":"2026-10-29T11:16:39.240Z","data_as_of":"2026-10-26","url":"https://www.findmykol.com/kol/lisa-bomgaars","json_url":"https://www.findmykol.com/kol/lisa-bomgaars/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"lisa-bomgaars","name":"Lisa Bomgaars","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Leukemia","therapeutic_areas":["Leukemia"],"institution":"Baylor College of Medicine","institution_url":"https://www.findmykol.com/institution/baylor-college-of-medicine","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1457431884","orcid":"0000-0002-0920-0717","openalex":"A5004008487"},"summary":"Lisa Bomgaars is a Pharmaceutical studies and practices physician affiliated with Baylor College of Medicine. OpenAlex indexes 72 publications with 4,001 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.","overview":{"text":"Lisa Bomgaars, MD, is affiliated with Baylor College of Medicine. The public record shows 72 publications with 4,001 citations (h-index 30), centered on Pharmaceutical studies and practices, Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 2 companies, 1 NIH-funded awards (1999–2008).","bullets":["Most recent indexed publication: 2022 · Blood advances","Top research focus: Pharmaceutical studies and practices","2 registered trials on ClinicalTrials.gov","Open Payments reporting from 2 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Central Nervous System Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Nervous System Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Astrocytoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuroblastoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Oligodendroglioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Medulloblastoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sarcoma, Ewing","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Meningioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Rhabdomyosarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Ependymoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuroectodermal Tumors, Primitive, Peripheral","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Coma","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Craniopharyngioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Myosarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neoplasms, Germ Cell and Embryonal","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1},{"label":"Atrial Fibrillation","therapeutic_area":"Cardiology","trials":0,"topics":1,"strength":1}],"research_topics":["Pharmaceutical studies and practices","Venous Thromboembolism Diagnosis and Management","Blood Coagulation and Thrombosis Mechanisms","Acute Lymphoblastic Leukemia research","Atrial Fibrillation Management and Outcomes"],"drugs_studied":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Pradaxa","generic":"Dabigatran etexilate","trials":0,"payments":1,"publications":2,"mentions":3},{"name":"Xarelto","generic":"Rivaroxaban","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Janssen Research & Development, LLC","trials":0,"payments":2,"mentions":2},{"name":"Boehringer Ingelheim Pharmaceuticals, Inc.","trials":0,"payments":1,"mentions":1},{"name":"Children's Oncology Group","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":72,"cited_by_count":4001,"h_index":30,"i10_index":45,"pubmed_count":1,"latest_activity_year":2022,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT00004078","title":"Irinotecan in Treating Children With Refractory Solid Tumors","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Children's Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT00004078","trial_url":"https://www.findmykol.com/trial/NCT00004078"},{"nct":"NCT00003241","title":"Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Texas Children's Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT00003241","trial_url":"https://www.findmykol.com/trial/NCT00003241"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":2022},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2022,"amount_usd":1429.41,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457431884"},{"payer":"Janssen Research & Development, LLC","program_year":2022,"amount_usd":585,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457431884"},{"payer":"Janssen Research & Development, LLC","program_year":2021,"amount_usd":585,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457431884"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1457431884","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":1999,"last":2008},"rows_total":7,"shown":3,"withheld":4,"rows":[{"project":"M01RR000188","title":"ASPIRIN RESISTANCE IN PEDIATRIC PATIENTS","fiscal_year":2008,"amount_usd":2231,"organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/M01RR000188"},{"project":"M01RR000188","title":"ASPIRIN RESISTANCE IN PEDIATRIC PATIENTS","fiscal_year":2007,"amount_usd":4980,"organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/M01RR000188"},{"project":"M01RR000188","title":"A MULTICENTER, OPEN-LABEL, SINGLE-ARM, TWO-STEP STUDY TO EVALUATE THE SAFETY","fiscal_year":2007,"amount_usd":3515,"organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/M01RR000188"}],"source":"grants"},"congress":{"count":6,"years":{"first":2005,"last":2023},"societies":["ASCO","ASH"],"shown":3,"withheld":3,"rows":[{"title":"The Quest for Improving Sickle Cell Care: Creating High-Level Quality Improvement Goals with a Care Process Team","society":"ASH","meeting":"ASH Annual Meeting","year":2023,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2023-191064","source_url":"https://doi.org/10.1182/blood-2023-191064","status":"verified"},{"title":"Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial","society":"ASH","meeting":"ASH Annual Meeting","year":2020,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2020-136682","source_url":"https://doi.org/10.1182/blood-2020-136682","status":"verified"},{"title":"Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia","society":"ASH","meeting":"ASH Annual Meeting","year":2020,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2020-136695","source_url":"https://doi.org/10.1182/blood-2020-136695","status":"verified"}],"source":"congress"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.","year":2022,"journal":"Blood advances","types":["Clinical Trial, Phase II","Clinical Trial, Phase III","Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/36150047/","status":"verified"}],"most_cited":{"total":72,"shown":5,"withheld":67,"rows":[{"title":"Prospective Trial of a Pediatric Ventricular Assist Device","year":2012,"cited_by_count":483,"type":"article","source_url":"https://doi.org/10.1056/nejmoa1014164"},{"title":"Preponderance of Thiopurine S-Methyltransferase Deficiency and Heterozygosity Among Patients Intolerant to Mercaptopurine or Azathioprine","year":2001,"cited_by_count":400,"type":"article","source_url":"https://doi.org/10.1200/jco.2001.19.8.2293"},{"title":"Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia","year":2006,"cited_by_count":308,"type":"article","source_url":"https://doi.org/10.1200/jco.2005.03.8554"},{"title":"A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia","year":2011,"cited_by_count":221,"type":"article","source_url":"https://doi.org/10.1182/blood-2010-10-313908"},{"title":"Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward","year":2016,"cited_by_count":189,"type":"article","source_url":"https://doi.org/10.1200/jco.2015.65.5381"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Susan M. Blaney","coauthored_works":18},{"name":"Stacey L. Berg","coauthored_works":15},{"name":"Manuela Albisetti","coauthored_works":13,"profile_url":"https://www.findmykol.com/kol/manuela-albisetti"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/lisa-bomgaars-md","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"similar":[{"name":"Christie Ballantyne","slug":"christie-ballantyne","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/christie-ballantyne","json_url":"https://www.findmykol.com/kol/christie-ballantyne/profile.json"},{"name":"Biykem Bozkurt","slug":"biykem-bozkurt","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/biykem-bozkurt","json_url":"https://www.findmykol.com/kol/biykem-bozkurt/profile.json"},{"name":"Malcolm Brenner","slug":"malcolm-brenner","institution":"Baylor College of Medicine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/malcolm-brenner","json_url":"https://www.findmykol.com/kol/malcolm-brenner/profile.json"},{"name":"Garabed Eknoyan","slug":"garabed-eknoyan","institution":"Baylor College of Medicine","specialty":"Nephrology","url":"https://www.findmykol.com/kol/garabed-eknoyan","json_url":"https://www.findmykol.com/kol/garabed-eknoyan/profile.json"},{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Jorge Cortes","slug":"jorge-cortes","institution":"University of Alabama at Birmingham (UAB)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/jorge-cortes","json_url":"https://www.findmykol.com/kol/jorge-cortes/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":4,"congress":3,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2022","collected_at":"2026-10-28"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-28"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-28"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}